The Gujarat government has announced big concessions to hospitality and health care industries and have allowed a floor space index that can go up to 4 against the 1.8 that exists now for hospital and hotel projects.
Indian generic firm Natco Pharma has sought US FDA's permission to market a low-cost version of the thalidomide based medicine Revlimid to treat multiple myeloma.
AAD-2004, an experimental drug which claims to treat major neurodegenerative diseases including Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS), may be around the corner.
One in every three first-time pregnant women in US is having cesarean delivery, according to a new study.
Atopaxar, a new drug being developed by Japanese drugmaker Eisai, could cut blood clotting in cardiovascular diseases without serious risks of bleeding that is common with the current antiplatelet therapies.